nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—Losartan—type 2 diabetes mellitus	0.17	1	CrCtD
Telmisartan—Angiotensin 2 Receptor Antagonists—Irbesartan—type 2 diabetes mellitus	0.104	0.37	CiPCiCtD
Telmisartan—coronary artery disease—type 2 diabetes mellitus	0.0949	0.626	CtDrD
Telmisartan—Angiotensin 2 Receptor Antagonists—Valsartan—type 2 diabetes mellitus	0.0883	0.315	CiPCiCtD
Telmisartan—Angiotensin 2 Receptor Antagonists—Losartan—type 2 diabetes mellitus	0.0883	0.315	CiPCiCtD
Telmisartan—hypertension—type 2 diabetes mellitus	0.0566	0.374	CtDrD
Telmisartan—PPARG—type 2 diabetes mellitus	0.0395	0.506	CbGaD
Telmisartan—ABCC2—type 2 diabetes mellitus	0.0386	0.494	CbGaD
Telmisartan—Azilsartan medoxomil—Losartan—type 2 diabetes mellitus	0.0177	0.141	CrCrCtD
Telmisartan—Olmesartan—Irbesartan—type 2 diabetes mellitus	0.0168	0.134	CrCrCtD
Telmisartan—PPARG—Glipizide—type 2 diabetes mellitus	0.0166	0.12	CbGbCtD
Telmisartan—Losartan—Irbesartan—type 2 diabetes mellitus	0.0153	0.122	CrCrCtD
Telmisartan—PPARG—Repaglinide—type 2 diabetes mellitus	0.0145	0.105	CbGbCtD
Telmisartan—Olmesartan—Valsartan—type 2 diabetes mellitus	0.0143	0.114	CrCrCtD
Telmisartan—Candesartan—Irbesartan—type 2 diabetes mellitus	0.0141	0.112	CrCrCtD
Telmisartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.0137	0.099	CbGbCtD
Telmisartan—PPARG—Pioglitazone—type 2 diabetes mellitus	0.0131	0.0948	CbGbCtD
Telmisartan—Losartan—Valsartan—type 2 diabetes mellitus	0.013	0.104	CrCrCtD
Telmisartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.0122	0.0883	CbGbCtD
Telmisartan—Olmesartan—Losartan—type 2 diabetes mellitus	0.0122	0.0969	CrCrCtD
Telmisartan—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.0121	0.0875	CbGbCtD
Telmisartan—Candesartan—Valsartan—type 2 diabetes mellitus	0.012	0.0953	CrCrCtD
Telmisartan—Candesartan—Losartan—type 2 diabetes mellitus	0.0102	0.081	CrCrCtD
Telmisartan—PPARG—Nateglinide—type 2 diabetes mellitus	0.00994	0.0718	CbGbCtD
Telmisartan—AGTR1—Losartan—type 2 diabetes mellitus	0.00787	0.0569	CbGbCtD
Telmisartan—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.00774	0.0559	CbGbCtD
Telmisartan—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.00631	0.0456	CbGbCtD
Telmisartan—SLCO1B3—Losartan—type 2 diabetes mellitus	0.00362	0.0262	CbGbCtD
Telmisartan—ABCC2—Glyburide—type 2 diabetes mellitus	0.00203	0.0147	CbGbCtD
Telmisartan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.002	0.0145	CbGbCtD
Telmisartan—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00188	0.0136	CbGbCtD
Telmisartan—ABCG2—Glyburide—type 2 diabetes mellitus	0.00183	0.0132	CbGbCtD
Telmisartan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00179	0.0129	CbGbCtD
Telmisartan—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0016	0.0116	CbGbCtD
Telmisartan—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0016	0.0116	CbGbCtD
Telmisartan—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00148	0.0107	CbGbCtD
Telmisartan—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00143	0.0103	CbGbCtD
Telmisartan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00129	0.00933	CbGbCtD
Telmisartan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.000887	0.00641	CbGbCtD
Telmisartan—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.000833	0.13	CbGeAlD
Telmisartan—CYP2C19—Glyburide—type 2 diabetes mellitus	0.000819	0.00592	CbGbCtD
Telmisartan—CYP2C19—Losartan—type 2 diabetes mellitus	0.000749	0.00541	CbGbCtD
Telmisartan—PPARG—leg—type 2 diabetes mellitus	0.00067	0.105	CbGeAlD
Telmisartan—ABCB1—Glyburide—type 2 diabetes mellitus	0.000661	0.00478	CbGbCtD
Telmisartan—ABCB1—Losartan—type 2 diabetes mellitus	0.000604	0.00437	CbGbCtD
Telmisartan—PPARG—hindlimb—type 2 diabetes mellitus	0.000599	0.0933	CbGeAlD
Telmisartan—AGTR1—artery—type 2 diabetes mellitus	0.000446	0.0696	CbGeAlD
Telmisartan—AGTR1—endothelium—type 2 diabetes mellitus	0.000377	0.0588	CbGeAlD
Telmisartan—PPARG—artery—type 2 diabetes mellitus	0.000367	0.0572	CbGeAlD
Telmisartan—PPARG—endothelium—type 2 diabetes mellitus	0.00031	0.0483	CbGeAlD
Telmisartan—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000176	0.0275	CbGeAlD
Telmisartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.000173	0.0269	CbGeAlD
Telmisartan—SLCO1B3—liver—type 2 diabetes mellitus	0.000158	0.0247	CbGeAlD
Telmisartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.000155	0.0242	CbGeAlD
Telmisartan—AGTR1—kidney—type 2 diabetes mellitus	0.000152	0.0237	CbGeAlD
Telmisartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.000148	0.023	CbGeAlD
Telmisartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.000137	0.0213	CbGeAlD
Telmisartan—Olmesartan—ABCC2—type 2 diabetes mellitus	0.000133	0.318	CrCbGaD
Telmisartan—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000128	0.0199	CbGeAlD
Telmisartan—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000125	0.0195	CbGeAlD
Telmisartan—PPARG—kidney—type 2 diabetes mellitus	0.000125	0.0195	CbGeAlD
Telmisartan—PPARG—pancreas—type 2 diabetes mellitus	0.000124	0.0193	CbGeAlD
Telmisartan—Deferasirox—CYP3A4—type 2 diabetes mellitus	0.000124	0.295	CrCbGaD
Telmisartan—PPARG—adipose tissue—type 2 diabetes mellitus	0.000112	0.0175	CbGeAlD
Telmisartan—ABCC2—kidney—type 2 diabetes mellitus	0.00011	0.0171	CbGeAlD
Telmisartan—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000107	0.0167	CbGeAlD
Telmisartan—AGTR1—liver—type 2 diabetes mellitus	9.59e-05	0.015	CbGeAlD
Telmisartan—ABCG2—nephron tubule—type 2 diabetes mellitus	9.1e-05	0.0142	CbGeAlD
Telmisartan—PPARG—liver—type 2 diabetes mellitus	7.89e-05	0.0123	CbGeAlD
Telmisartan—ABCG2—adipose tissue—type 2 diabetes mellitus	7.21e-05	0.0112	CbGeAlD
Telmisartan—ABCC2—liver—type 2 diabetes mellitus	6.93e-05	0.0108	CbGeAlD
Telmisartan—Losartan—ACE—type 2 diabetes mellitus	6.28e-05	0.15	CrCbGaD
Telmisartan—CYP2C19—liver—type 2 diabetes mellitus	5.96e-05	0.00929	CbGeAlD
Telmisartan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	5.57e-05	0.00869	CbGeAlD
Telmisartan—ABCG2—liver—type 2 diabetes mellitus	5.06e-05	0.00788	CbGeAlD
Telmisartan—ABCB1—retina—type 2 diabetes mellitus	4.77e-05	0.00743	CbGeAlD
Telmisartan—ABCB1—nephron tubule—type 2 diabetes mellitus	4.49e-05	0.007	CbGeAlD
Telmisartan—Losartan—CYP1A2—type 2 diabetes mellitus	4.46e-05	0.106	CrCbGaD
Telmisartan—ABCB1—cardiovascular system—type 2 diabetes mellitus	4.03e-05	0.00628	CbGeAlD
Telmisartan—ABCB1—kidney—type 2 diabetes mellitus	3.94e-05	0.00615	CbGeAlD
Telmisartan—ABCB1—pancreas—type 2 diabetes mellitus	3.92e-05	0.00611	CbGeAlD
Telmisartan—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.84e-05	0.00599	CbGeAlD
Telmisartan—ABCB1—adipose tissue—type 2 diabetes mellitus	3.55e-05	0.00554	CbGeAlD
Telmisartan—Losartan—CYP3A4—type 2 diabetes mellitus	2.95e-05	0.0703	CrCbGaD
Telmisartan—Losartan—ALB—type 2 diabetes mellitus	2.57e-05	0.0613	CrCbGaD
Telmisartan—ABCB1—liver—type 2 diabetes mellitus	2.49e-05	0.00389	CbGeAlD
Telmisartan—Chest pain—Irbesartan—type 2 diabetes mellitus	1.3e-05	0.000377	CcSEcCtD
Telmisartan—Shock—Metformin—type 2 diabetes mellitus	1.3e-05	0.000377	CcSEcCtD
Telmisartan—Insomnia—Orlistat—type 2 diabetes mellitus	1.3e-05	0.000376	CcSEcCtD
Telmisartan—Malaise—Losartan—type 2 diabetes mellitus	1.3e-05	0.000376	CcSEcCtD
Telmisartan—Anxiety—Irbesartan—type 2 diabetes mellitus	1.3e-05	0.000376	CcSEcCtD
Telmisartan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.3e-05	0.000376	CcSEcCtD
Telmisartan—Nervous system disorder—Metformin—type 2 diabetes mellitus	1.3e-05	0.000376	CcSEcCtD
Telmisartan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.29e-05	0.000375	CcSEcCtD
Telmisartan—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.29e-05	0.000375	CcSEcCtD
Telmisartan—Vertigo—Losartan—type 2 diabetes mellitus	1.29e-05	0.000375	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	1.29e-05	0.000375	CcSEcCtD
Telmisartan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.29e-05	0.000375	CcSEcCtD
Telmisartan—Somnolence—Valsartan—type 2 diabetes mellitus	1.29e-05	0.000374	CcSEcCtD
Telmisartan—Syncope—Losartan—type 2 diabetes mellitus	1.29e-05	0.000374	CcSEcCtD
Telmisartan—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.29e-05	0.000373	CcSEcCtD
Telmisartan—Discomfort—Irbesartan—type 2 diabetes mellitus	1.28e-05	0.000373	CcSEcCtD
Telmisartan—Skin disorder—Metformin—type 2 diabetes mellitus	1.28e-05	0.000372	CcSEcCtD
Telmisartan—Immune system disorder—Ramipril—type 2 diabetes mellitus	1.28e-05	0.000371	CcSEcCtD
Telmisartan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.28e-05	0.00037	CcSEcCtD
Telmisartan—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.28e-05	0.00037	CcSEcCtD
Telmisartan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	1.28e-05	0.00037	CcSEcCtD
Telmisartan—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.27e-05	0.000369	CcSEcCtD
Telmisartan—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000369	CcSEcCtD
Telmisartan—Palpitations—Losartan—type 2 diabetes mellitus	1.27e-05	0.000368	CcSEcCtD
Telmisartan—Nausea—Glimepiride—type 2 diabetes mellitus	1.27e-05	0.000367	CcSEcCtD
Telmisartan—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000367	CcSEcCtD
Telmisartan—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.26e-05	0.000366	CcSEcCtD
Telmisartan—Nausea—Sitagliptin—type 2 diabetes mellitus	1.26e-05	0.000366	CcSEcCtD
Telmisartan—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.26e-05	0.000366	CcSEcCtD
Telmisartan—Asthenia—Glyburide—type 2 diabetes mellitus	1.26e-05	0.000366	CcSEcCtD
Telmisartan—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.26e-05	0.000366	CcSEcCtD
Telmisartan—Anorexia—Metformin—type 2 diabetes mellitus	1.26e-05	0.000365	CcSEcCtD
Telmisartan—Cough—Losartan—type 2 diabetes mellitus	1.25e-05	0.000364	CcSEcCtD
Telmisartan—Urticaria—Gliclazide—type 2 diabetes mellitus	1.25e-05	0.000364	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.25e-05	0.000363	CcSEcCtD
Telmisartan—Fatigue—Valsartan—type 2 diabetes mellitus	1.25e-05	0.000363	CcSEcCtD
Telmisartan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.25e-05	0.000362	CcSEcCtD
Telmisartan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.25e-05	0.000362	CcSEcCtD
Telmisartan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	1.25e-05	0.000362	CcSEcCtD
Telmisartan—Oedema—Irbesartan—type 2 diabetes mellitus	1.25e-05	0.000362	CcSEcCtD
Telmisartan—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.25e-05	0.000361	CcSEcCtD
Telmisartan—Pruritus—Glyburide—type 2 diabetes mellitus	1.24e-05	0.000361	CcSEcCtD
Telmisartan—Mental disorder—Ramipril—type 2 diabetes mellitus	1.24e-05	0.00036	CcSEcCtD
Telmisartan—Constipation—Valsartan—type 2 diabetes mellitus	1.24e-05	0.00036	CcSEcCtD
Telmisartan—Infection—Irbesartan—type 2 diabetes mellitus	1.24e-05	0.000359	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.24e-05	0.000359	CcSEcCtD
Telmisartan—Fatigue—Orlistat—type 2 diabetes mellitus	1.24e-05	0.000358	CcSEcCtD
Telmisartan—Hypotension—Metformin—type 2 diabetes mellitus	1.23e-05	0.000358	CcSEcCtD
Telmisartan—Malnutrition—Ramipril—type 2 diabetes mellitus	1.23e-05	0.000358	CcSEcCtD
Telmisartan—Erythema—Ramipril—type 2 diabetes mellitus	1.23e-05	0.000358	CcSEcCtD
Telmisartan—Shock—Irbesartan—type 2 diabetes mellitus	1.23e-05	0.000356	CcSEcCtD
Telmisartan—Pain—Orlistat—type 2 diabetes mellitus	1.23e-05	0.000356	CcSEcCtD
Telmisartan—Arthralgia—Losartan—type 2 diabetes mellitus	1.22e-05	0.000355	CcSEcCtD
Telmisartan—Chest pain—Losartan—type 2 diabetes mellitus	1.22e-05	0.000355	CcSEcCtD
Telmisartan—Myalgia—Losartan—type 2 diabetes mellitus	1.22e-05	0.000355	CcSEcCtD
Telmisartan—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.22e-05	0.000355	CcSEcCtD
Telmisartan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	1.22e-05	0.000355	CcSEcCtD
Telmisartan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.22e-05	0.000354	CcSEcCtD
Telmisartan—Anxiety—Losartan—type 2 diabetes mellitus	1.22e-05	0.000354	CcSEcCtD
Telmisartan—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.22e-05	0.000353	CcSEcCtD
Telmisartan—Rash—Bromocriptine—type 2 diabetes mellitus	1.21e-05	0.000352	CcSEcCtD
Telmisartan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.21e-05	0.000351	CcSEcCtD
Telmisartan—Skin disorder—Irbesartan—type 2 diabetes mellitus	1.21e-05	0.000351	CcSEcCtD
Telmisartan—Tension—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000351	CcSEcCtD
Telmisartan—Discomfort—Losartan—type 2 diabetes mellitus	1.21e-05	0.000351	CcSEcCtD
Telmisartan—Dysgeusia—Ramipril—type 2 diabetes mellitus	1.21e-05	0.00035	CcSEcCtD
Telmisartan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.2e-05	0.00035	CcSEcCtD
Telmisartan—Headache—Bromocriptine—type 2 diabetes mellitus	1.2e-05	0.00035	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.2e-05	0.000349	CcSEcCtD
Telmisartan—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.2e-05	0.000349	CcSEcCtD
Telmisartan—Nervousness—Ramipril—type 2 diabetes mellitus	1.2e-05	0.000347	CcSEcCtD
Telmisartan—Dry mouth—Losartan—type 2 diabetes mellitus	1.2e-05	0.000347	CcSEcCtD
Telmisartan—Anorexia—Irbesartan—type 2 diabetes mellitus	1.19e-05	0.000345	CcSEcCtD
Telmisartan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.19e-05	0.000344	CcSEcCtD
Telmisartan—Paraesthesia—Metformin—type 2 diabetes mellitus	1.19e-05	0.000344	CcSEcCtD
Telmisartan—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.18e-05	0.000344	CcSEcCtD
Telmisartan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.18e-05	0.000343	CcSEcCtD
Telmisartan—Dyspnoea—Metformin—type 2 diabetes mellitus	1.18e-05	0.000342	CcSEcCtD
Telmisartan—Somnolence—Metformin—type 2 diabetes mellitus	1.17e-05	0.000341	CcSEcCtD
Telmisartan—Oedema—Losartan—type 2 diabetes mellitus	1.17e-05	0.00034	CcSEcCtD
Telmisartan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	1.17e-05	0.00034	CcSEcCtD
Telmisartan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.17e-05	0.00034	CcSEcCtD
Telmisartan—Infection—Losartan—type 2 diabetes mellitus	1.17e-05	0.000338	CcSEcCtD
Telmisartan—Hypotension—Irbesartan—type 2 diabetes mellitus	1.16e-05	0.000338	CcSEcCtD
Telmisartan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.16e-05	0.000337	CcSEcCtD
Telmisartan—Dyspepsia—Metformin—type 2 diabetes mellitus	1.16e-05	0.000337	CcSEcCtD
Telmisartan—Shock—Losartan—type 2 diabetes mellitus	1.15e-05	0.000335	CcSEcCtD
Telmisartan—Urticaria—Valsartan—type 2 diabetes mellitus	1.15e-05	0.000334	CcSEcCtD
Telmisartan—Nervous system disorder—Losartan—type 2 diabetes mellitus	1.15e-05	0.000334	CcSEcCtD
Telmisartan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.15e-05	0.000333	CcSEcCtD
Telmisartan—Decreased appetite—Metformin—type 2 diabetes mellitus	1.15e-05	0.000333	CcSEcCtD
Telmisartan—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.15e-05	0.000333	CcSEcCtD
Telmisartan—Tachycardia—Losartan—type 2 diabetes mellitus	1.14e-05	0.000332	CcSEcCtD
Telmisartan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.14e-05	0.000332	CcSEcCtD
Telmisartan—Nausea—Bromocriptine—type 2 diabetes mellitus	1.14e-05	0.000331	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.14e-05	0.000331	CcSEcCtD
Telmisartan—Fatigue—Metformin—type 2 diabetes mellitus	1.14e-05	0.00033	CcSEcCtD
Telmisartan—Urticaria—Orlistat—type 2 diabetes mellitus	1.14e-05	0.00033	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.14e-05	0.000329	CcSEcCtD
Telmisartan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.13e-05	0.000329	CcSEcCtD
Telmisartan—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.13e-05	0.000329	CcSEcCtD
Telmisartan—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.13e-05	0.000329	CcSEcCtD
Telmisartan—Asthenia—Gliclazide—type 2 diabetes mellitus	1.13e-05	0.000329	CcSEcCtD
Telmisartan—Constipation—Metformin—type 2 diabetes mellitus	1.13e-05	0.000328	CcSEcCtD
Telmisartan—Angioedema—Ramipril—type 2 diabetes mellitus	1.13e-05	0.000327	CcSEcCtD
Telmisartan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.12e-05	0.000325	CcSEcCtD
Telmisartan—Anorexia—Losartan—type 2 diabetes mellitus	1.12e-05	0.000324	CcSEcCtD
Telmisartan—Vomiting—Glyburide—type 2 diabetes mellitus	1.12e-05	0.000324	CcSEcCtD
Telmisartan—Pruritus—Gliclazide—type 2 diabetes mellitus	1.12e-05	0.000324	CcSEcCtD
Telmisartan—Malaise—Ramipril—type 2 diabetes mellitus	1.11e-05	0.000322	CcSEcCtD
Telmisartan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.11e-05	0.000322	CcSEcCtD
Telmisartan—Rash—Glyburide—type 2 diabetes mellitus	1.11e-05	0.000322	CcSEcCtD
Telmisartan—Somnolence—Irbesartan—type 2 diabetes mellitus	1.11e-05	0.000321	CcSEcCtD
Telmisartan—Dermatitis—Glyburide—type 2 diabetes mellitus	1.11e-05	0.000321	CcSEcCtD
Telmisartan—Vertigo—Ramipril—type 2 diabetes mellitus	1.11e-05	0.000321	CcSEcCtD
Telmisartan—Syncope—Ramipril—type 2 diabetes mellitus	1.11e-05	0.000321	CcSEcCtD
Telmisartan—Headache—Glyburide—type 2 diabetes mellitus	1.1e-05	0.00032	CcSEcCtD
Telmisartan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000318	CcSEcCtD
Telmisartan—Hypotension—Losartan—type 2 diabetes mellitus	1.1e-05	0.000318	CcSEcCtD
Telmisartan—Palpitations—Ramipril—type 2 diabetes mellitus	1.09e-05	0.000316	CcSEcCtD
Telmisartan—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.09e-05	0.000316	CcSEcCtD
Telmisartan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.08e-05	0.000314	CcSEcCtD
Telmisartan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.08e-05	0.000314	CcSEcCtD
Telmisartan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.08e-05	0.000313	CcSEcCtD
Telmisartan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.08e-05	0.000313	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.08e-05	0.000312	CcSEcCtD
Telmisartan—Cough—Ramipril—type 2 diabetes mellitus	1.08e-05	0.000312	CcSEcCtD
Telmisartan—Fatigue—Irbesartan—type 2 diabetes mellitus	1.07e-05	0.000312	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.07e-05	0.00031	CcSEcCtD
Telmisartan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.07e-05	0.00031	CcSEcCtD
Telmisartan—Pain—Irbesartan—type 2 diabetes mellitus	1.07e-05	0.000309	CcSEcCtD
Telmisartan—Constipation—Irbesartan—type 2 diabetes mellitus	1.07e-05	0.000309	CcSEcCtD
Telmisartan—Insomnia—Losartan—type 2 diabetes mellitus	1.06e-05	0.000308	CcSEcCtD
Telmisartan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.06e-05	0.000306	CcSEcCtD
Telmisartan—Paraesthesia—Losartan—type 2 diabetes mellitus	1.05e-05	0.000306	CcSEcCtD
Telmisartan—Urticaria—Metformin—type 2 diabetes mellitus	1.05e-05	0.000304	CcSEcCtD
Telmisartan—Myalgia—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000304	CcSEcCtD
Telmisartan—Chest pain—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000304	CcSEcCtD
Telmisartan—Arthralgia—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000304	CcSEcCtD
Telmisartan—Dyspnoea—Losartan—type 2 diabetes mellitus	1.05e-05	0.000303	CcSEcCtD
Telmisartan—Anxiety—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000303	CcSEcCtD
Telmisartan—Nausea—Glyburide—type 2 diabetes mellitus	1.04e-05	0.000303	CcSEcCtD
Telmisartan—Abdominal pain—Metformin—type 2 diabetes mellitus	1.04e-05	0.000303	CcSEcCtD
Telmisartan—Dizziness—Gliclazide—type 2 diabetes mellitus	1.04e-05	0.000303	CcSEcCtD
Telmisartan—Somnolence—Losartan—type 2 diabetes mellitus	1.04e-05	0.000303	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	1.04e-05	0.000302	CcSEcCtD
Telmisartan—Asthenia—Valsartan—type 2 diabetes mellitus	1.04e-05	0.000302	CcSEcCtD
Telmisartan—Discomfort—Ramipril—type 2 diabetes mellitus	1.04e-05	0.000301	CcSEcCtD
Telmisartan—Dyspepsia—Losartan—type 2 diabetes mellitus	1.03e-05	0.0003	CcSEcCtD
Telmisartan—Asthenia—Orlistat—type 2 diabetes mellitus	1.03e-05	0.000298	CcSEcCtD
Telmisartan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.03e-05	0.000298	CcSEcCtD
Telmisartan—Pruritus—Valsartan—type 2 diabetes mellitus	1.03e-05	0.000298	CcSEcCtD
Telmisartan—Dry mouth—Ramipril—type 2 diabetes mellitus	1.03e-05	0.000298	CcSEcCtD
Telmisartan—Decreased appetite—Losartan—type 2 diabetes mellitus	1.02e-05	0.000296	CcSEcCtD
Telmisartan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.02e-05	0.000296	CcSEcCtD
Telmisartan—Pruritus—Orlistat—type 2 diabetes mellitus	1.01e-05	0.000294	CcSEcCtD
Telmisartan—Fatigue—Losartan—type 2 diabetes mellitus	1.01e-05	0.000293	CcSEcCtD
Telmisartan—Oedema—Ramipril—type 2 diabetes mellitus	1.01e-05	0.000292	CcSEcCtD
Telmisartan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	1.01e-05	0.000292	CcSEcCtD
Telmisartan—Vomiting—Gliclazide—type 2 diabetes mellitus	1e-05	0.000291	CcSEcCtD
Telmisartan—Constipation—Losartan—type 2 diabetes mellitus	1e-05	0.000291	CcSEcCtD
Telmisartan—Pain—Losartan—type 2 diabetes mellitus	1e-05	0.000291	CcSEcCtD
Telmisartan—Rash—Gliclazide—type 2 diabetes mellitus	9.95e-06	0.000289	CcSEcCtD
Telmisartan—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.94e-06	0.000289	CcSEcCtD
Telmisartan—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.92e-06	0.000288	CcSEcCtD
Telmisartan—Urticaria—Irbesartan—type 2 diabetes mellitus	9.9e-06	0.000287	CcSEcCtD
Telmisartan—Shock—Ramipril—type 2 diabetes mellitus	9.89e-06	0.000287	CcSEcCtD
Telmisartan—Headache—Gliclazide—type 2 diabetes mellitus	9.89e-06	0.000287	CcSEcCtD
Telmisartan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.86e-06	0.000286	CcSEcCtD
Telmisartan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.85e-06	0.000286	CcSEcCtD
Telmisartan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.85e-06	0.000286	CcSEcCtD
Telmisartan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.85e-06	0.000286	CcSEcCtD
Telmisartan—Tachycardia—Ramipril—type 2 diabetes mellitus	9.82e-06	0.000285	CcSEcCtD
Telmisartan—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.8e-06	0.000284	CcSEcCtD
Telmisartan—Skin disorder—Ramipril—type 2 diabetes mellitus	9.77e-06	0.000283	CcSEcCtD
Telmisartan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.72e-06	0.000282	CcSEcCtD
Telmisartan—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.66e-06	0.00028	CcSEcCtD
Telmisartan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.59e-06	0.000278	CcSEcCtD
Telmisartan—Dizziness—Valsartan—type 2 diabetes mellitus	9.59e-06	0.000278	CcSEcCtD
Telmisartan—Anorexia—Ramipril—type 2 diabetes mellitus	9.59e-06	0.000278	CcSEcCtD
Telmisartan—Dizziness—Orlistat—type 2 diabetes mellitus	9.48e-06	0.000275	CcSEcCtD
Telmisartan—Asthenia—Metformin—type 2 diabetes mellitus	9.47e-06	0.000275	CcSEcCtD
Telmisartan—Hypotension—Ramipril—type 2 diabetes mellitus	9.4e-06	0.000273	CcSEcCtD
Telmisartan—Nausea—Gliclazide—type 2 diabetes mellitus	9.38e-06	0.000272	CcSEcCtD
Telmisartan—Pruritus—Metformin—type 2 diabetes mellitus	9.34e-06	0.000271	CcSEcCtD
Telmisartan—Urticaria—Losartan—type 2 diabetes mellitus	9.32e-06	0.00027	CcSEcCtD
Telmisartan—Abdominal pain—Losartan—type 2 diabetes mellitus	9.27e-06	0.000269	CcSEcCtD
Telmisartan—Body temperature increased—Losartan—type 2 diabetes mellitus	9.27e-06	0.000269	CcSEcCtD
Telmisartan—Vomiting—Valsartan—type 2 diabetes mellitus	9.22e-06	0.000268	CcSEcCtD
Telmisartan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.18e-06	0.000266	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.16e-06	0.000266	CcSEcCtD
Telmisartan—Rash—Valsartan—type 2 diabetes mellitus	9.14e-06	0.000265	CcSEcCtD
Telmisartan—Dermatitis—Valsartan—type 2 diabetes mellitus	9.14e-06	0.000265	CcSEcCtD
Telmisartan—Vomiting—Orlistat—type 2 diabetes mellitus	9.11e-06	0.000264	CcSEcCtD
Telmisartan—Insomnia—Ramipril—type 2 diabetes mellitus	9.1e-06	0.000264	CcSEcCtD
Telmisartan—Headache—Valsartan—type 2 diabetes mellitus	9.08e-06	0.000264	CcSEcCtD
Telmisartan—Diarrhoea—Metformin—type 2 diabetes mellitus	9.04e-06	0.000262	CcSEcCtD
Telmisartan—Rash—Orlistat—type 2 diabetes mellitus	9.04e-06	0.000262	CcSEcCtD
Telmisartan—Paraesthesia—Ramipril—type 2 diabetes mellitus	9.03e-06	0.000262	CcSEcCtD
Telmisartan—Dermatitis—Orlistat—type 2 diabetes mellitus	9.03e-06	0.000262	CcSEcCtD
Telmisartan—Headache—Orlistat—type 2 diabetes mellitus	8.98e-06	0.00026	CcSEcCtD
Telmisartan—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.97e-06	0.00026	CcSEcCtD
Telmisartan—Asthenia—Irbesartan—type 2 diabetes mellitus	8.94e-06	0.000259	CcSEcCtD
Telmisartan—Somnolence—Ramipril—type 2 diabetes mellitus	8.94e-06	0.000259	CcSEcCtD
Telmisartan—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.85e-06	0.000257	CcSEcCtD
Telmisartan—Pruritus—Irbesartan—type 2 diabetes mellitus	8.82e-06	0.000256	CcSEcCtD
Telmisartan—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.74e-06	0.000254	CcSEcCtD
Telmisartan—Dizziness—Metformin—type 2 diabetes mellitus	8.73e-06	0.000253	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.68e-06	0.000252	CcSEcCtD
Telmisartan—Fatigue—Ramipril—type 2 diabetes mellitus	8.67e-06	0.000252	CcSEcCtD
Telmisartan—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.64e-06	0.000251	CcSEcCtD
Telmisartan—Nausea—Valsartan—type 2 diabetes mellitus	8.61e-06	0.00025	CcSEcCtD
Telmisartan—Constipation—Ramipril—type 2 diabetes mellitus	8.6e-06	0.00025	CcSEcCtD
Telmisartan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.53e-06	0.000247	CcSEcCtD
Telmisartan—Nausea—Orlistat—type 2 diabetes mellitus	8.51e-06	0.000247	CcSEcCtD
Telmisartan—Asthenia—Losartan—type 2 diabetes mellitus	8.41e-06	0.000244	CcSEcCtD
Telmisartan—Vomiting—Metformin—type 2 diabetes mellitus	8.4e-06	0.000244	CcSEcCtD
Telmisartan—Rash—Metformin—type 2 diabetes mellitus	8.33e-06	0.000242	CcSEcCtD
Telmisartan—Dermatitis—Metformin—type 2 diabetes mellitus	8.32e-06	0.000241	CcSEcCtD
Telmisartan—Pruritus—Losartan—type 2 diabetes mellitus	8.3e-06	0.000241	CcSEcCtD
Telmisartan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.29e-06	0.00024	CcSEcCtD
Telmisartan—Headache—Metformin—type 2 diabetes mellitus	8.27e-06	0.00024	CcSEcCtD
Telmisartan—Dizziness—Irbesartan—type 2 diabetes mellitus	8.24e-06	0.000239	CcSEcCtD
Telmisartan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.22e-06	0.000239	CcSEcCtD
Telmisartan—Diarrhoea—Losartan—type 2 diabetes mellitus	8.02e-06	0.000233	CcSEcCtD
Telmisartan—Urticaria—Ramipril—type 2 diabetes mellitus	7.99e-06	0.000232	CcSEcCtD
Telmisartan—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.95e-06	0.000231	CcSEcCtD
Telmisartan—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.95e-06	0.000231	CcSEcCtD
Telmisartan—Vomiting—Irbesartan—type 2 diabetes mellitus	7.92e-06	0.00023	CcSEcCtD
Telmisartan—Rash—Irbesartan—type 2 diabetes mellitus	7.86e-06	0.000228	CcSEcCtD
Telmisartan—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.85e-06	0.000228	CcSEcCtD
Telmisartan—Nausea—Metformin—type 2 diabetes mellitus	7.84e-06	0.000228	CcSEcCtD
Telmisartan—Headache—Irbesartan—type 2 diabetes mellitus	7.81e-06	0.000227	CcSEcCtD
Telmisartan—Dizziness—Losartan—type 2 diabetes mellitus	7.76e-06	0.000225	CcSEcCtD
Telmisartan—Vomiting—Losartan—type 2 diabetes mellitus	7.46e-06	0.000216	CcSEcCtD
Telmisartan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.41e-06	0.000215	CcSEcCtD
Telmisartan—Nausea—Irbesartan—type 2 diabetes mellitus	7.4e-06	0.000215	CcSEcCtD
Telmisartan—Rash—Losartan—type 2 diabetes mellitus	7.39e-06	0.000215	CcSEcCtD
Telmisartan—Dermatitis—Losartan—type 2 diabetes mellitus	7.39e-06	0.000214	CcSEcCtD
Telmisartan—Headache—Losartan—type 2 diabetes mellitus	7.35e-06	0.000213	CcSEcCtD
Telmisartan—Asthenia—Ramipril—type 2 diabetes mellitus	7.22e-06	0.000209	CcSEcCtD
Telmisartan—Pruritus—Ramipril—type 2 diabetes mellitus	7.12e-06	0.000206	CcSEcCtD
Telmisartan—Nausea—Losartan—type 2 diabetes mellitus	6.97e-06	0.000202	CcSEcCtD
Telmisartan—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.88e-06	0.0002	CcSEcCtD
Telmisartan—Dizziness—Ramipril—type 2 diabetes mellitus	6.65e-06	0.000193	CcSEcCtD
Telmisartan—Vomiting—Ramipril—type 2 diabetes mellitus	6.39e-06	0.000186	CcSEcCtD
Telmisartan—Rash—Ramipril—type 2 diabetes mellitus	6.34e-06	0.000184	CcSEcCtD
Telmisartan—Dermatitis—Ramipril—type 2 diabetes mellitus	6.34e-06	0.000184	CcSEcCtD
Telmisartan—Headache—Ramipril—type 2 diabetes mellitus	6.3e-06	0.000183	CcSEcCtD
Telmisartan—Nausea—Ramipril—type 2 diabetes mellitus	5.97e-06	0.000173	CcSEcCtD
Telmisartan—ABCG2—Metabolism—HMGCR—type 2 diabetes mellitus	1.94e-06	0.000131	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARA—type 2 diabetes mellitus	1.92e-06	0.00013	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.92e-06	0.00013	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.91e-06	0.000129	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.91e-06	0.000129	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—type 2 diabetes mellitus	1.9e-06	0.000128	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.9e-06	0.000128	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.89e-06	0.000128	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—type 2 diabetes mellitus	1.89e-06	0.000128	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	1.88e-06	0.000127	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	1.88e-06	0.000127	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—C3—type 2 diabetes mellitus	1.88e-06	0.000127	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AGT—type 2 diabetes mellitus	1.86e-06	0.000126	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—LPL—type 2 diabetes mellitus	1.86e-06	0.000125	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	1.85e-06	0.000125	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.85e-06	0.000125	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.84e-06	0.000124	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.84e-06	0.000124	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CALM1—type 2 diabetes mellitus	1.83e-06	0.000124	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.83e-06	0.000123	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—type 2 diabetes mellitus	1.82e-06	0.000123	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.82e-06	0.000123	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.82e-06	0.000123	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.82e-06	0.000123	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.82e-06	0.000123	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ADCY5—type 2 diabetes mellitus	1.82e-06	0.000123	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GPX1—type 2 diabetes mellitus	1.81e-06	0.000122	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—type 2 diabetes mellitus	1.81e-06	0.000122	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.81e-06	0.000122	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOA1—type 2 diabetes mellitus	1.8e-06	0.000122	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.8e-06	0.000121	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.8e-06	0.000121	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.79e-06	0.000121	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.79e-06	0.000121	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.78e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.78e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.78e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.78e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.78e-06	0.00012	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CD36—type 2 diabetes mellitus	1.76e-06	0.000119	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.76e-06	0.000119	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.75e-06	0.000118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.75e-06	0.000118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.75e-06	0.000118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.75e-06	0.000118	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PPP2CA—type 2 diabetes mellitus	1.74e-06	0.000118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.73e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GCG—type 2 diabetes mellitus	1.73e-06	0.000116	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.73e-06	0.000116	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.72e-06	0.000116	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.71e-06	0.000115	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.71e-06	0.000115	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.69e-06	0.000114	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.68e-06	0.000114	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—type 2 diabetes mellitus	1.67e-06	0.000113	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.67e-06	0.000113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.65e-06	0.000111	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.64e-06	0.000111	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PPARA—type 2 diabetes mellitus	1.64e-06	0.000111	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.64e-06	0.00011	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.63e-06	0.00011	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.6e-06	0.000108	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.6e-06	0.000108	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.6e-06	0.000108	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—type 2 diabetes mellitus	1.59e-06	0.000107	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AGT—type 2 diabetes mellitus	1.59e-06	0.000107	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.57e-06	0.000106	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.56e-06	0.000106	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CALM1—type 2 diabetes mellitus	1.56e-06	0.000105	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.56e-06	0.000105	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—INS—type 2 diabetes mellitus	1.56e-06	0.000105	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—type 2 diabetes mellitus	1.56e-06	0.000105	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.55e-06	0.000104	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.55e-06	0.000104	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.55e-06	0.000104	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.55e-06	0.000104	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOA1—type 2 diabetes mellitus	1.54e-06	0.000104	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.53e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.53e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.51e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.51e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.51e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.51e-06	0.000102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	1.49e-06	0.000101	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.49e-06	0.0001	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.49e-06	0.0001	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNB3—type 2 diabetes mellitus	1.49e-06	0.0001	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.48e-06	0.0001	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMOX1—type 2 diabetes mellitus	1.48e-06	9.99e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.47e-06	9.92e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—type 2 diabetes mellitus	1.46e-06	9.86e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAT—type 2 diabetes mellitus	1.46e-06	9.86e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.45e-06	9.77e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.44e-06	9.75e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.44e-06	9.74e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.44e-06	9.72e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.44e-06	9.7e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—type 2 diabetes mellitus	1.43e-06	9.64e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	1.42e-06	9.57e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.41e-06	9.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.4e-06	9.42e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.38e-06	9.32e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	1.38e-06	9.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.38e-06	9.31e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.37e-06	9.26e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—type 2 diabetes mellitus	1.37e-06	9.23e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.37e-06	9.23e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	1.35e-06	9.14e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—type 2 diabetes mellitus	1.35e-06	9.1e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.35e-06	9.08e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—INS—type 2 diabetes mellitus	1.33e-06	8.98e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-06	8.95e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	1.32e-06	8.92e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.31e-06	8.84e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.31e-06	8.84e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.29e-06	8.74e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	1.29e-06	8.69e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	1.29e-06	8.68e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.27e-06	8.58e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	1.26e-06	8.51e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	1.26e-06	8.51e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.26e-06	8.48e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	1.25e-06	8.44e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	1.24e-06	8.35e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	8.32e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.23e-06	8.31e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.23e-06	8.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.23e-06	8.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	1.23e-06	8.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	1.23e-06	8.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	1.23e-06	8.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	1.22e-06	8.24e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—type 2 diabetes mellitus	1.22e-06	8.23e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	1.22e-06	8.23e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.21e-06	8.15e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	1.2e-06	8.1e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.2e-06	8.1e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.2e-06	8.1e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.2e-06	8.1e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-06	8.07e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.19e-06	8.05e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	1.19e-06	8e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.17e-06	7.9e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3R1—type 2 diabetes mellitus	1.17e-06	7.87e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—type 2 diabetes mellitus	1.17e-06	7.87e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	1.16e-06	7.82e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.16e-06	7.81e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-06	7.69e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.14e-06	7.67e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.13e-06	7.66e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.12e-06	7.58e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.12e-06	7.57e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	7.51e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.11e-06	7.46e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	7.46e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	1.1e-06	7.44e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.1e-06	7.44e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	1.1e-06	7.44e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.08e-06	7.3e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.08e-06	7.26e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.08e-06	7.26e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.08e-06	7.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.07e-06	7.24e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.07e-06	7.2e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.06e-06	7.14e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.06e-06	7.13e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.05e-06	7.09e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.05e-06	7.08e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.05e-06	7.06e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.04e-06	7.02e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.03e-06	6.93e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.02e-06	6.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.02e-06	6.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.01e-06	6.81e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	9.97e-07	6.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	9.97e-07	6.73e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	9.88e-07	6.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.84e-07	6.64e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.73e-07	6.57e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.73e-07	6.57e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	9.72e-07	6.56e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—INS—type 2 diabetes mellitus	9.69e-07	6.54e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.69e-07	6.54e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.67e-07	6.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	9.56e-07	6.45e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	9.56e-07	6.45e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.49e-07	6.41e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.43e-07	6.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	9.33e-07	6.3e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.33e-07	6.3e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	8.89e-07	6e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.66e-07	5.85e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.5e-07	5.74e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	8.5e-07	5.74e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.49e-07	5.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.24e-07	5.56e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	8.24e-07	5.56e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	8.2e-07	5.54e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	8.09e-07	5.46e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.04e-07	5.43e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	8.04e-07	5.43e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	8e-07	5.4e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.9e-07	5.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	7.85e-07	5.3e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	7.77e-07	5.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	7.66e-07	5.17e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	7.64e-07	5.16e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	7.5e-07	5.06e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	7.46e-07	5.03e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	7.34e-07	4.96e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	7.32e-07	4.94e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	7.32e-07	4.94e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	7.16e-07	4.84e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	7.14e-07	4.82e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	7.12e-07	4.81e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	7.04e-07	4.75e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.95e-07	4.69e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	6.89e-07	4.65e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.87e-07	4.64e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	6.75e-07	4.56e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	6.62e-07	4.47e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	6.59e-07	4.45e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.52e-07	4.41e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	6.46e-07	4.36e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	6.41e-07	4.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	6.31e-07	4.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	6.29e-07	4.24e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	6.28e-07	4.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	6.26e-07	4.23e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	6.21e-07	4.19e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	6.16e-07	4.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	6.13e-07	4.14e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	6.06e-07	4.09e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.02e-07	4.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	5.47e-07	3.7e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	5.37e-07	3.63e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	5.36e-07	3.62e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	5.34e-07	3.61e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.24e-07	3.54e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	4.92e-07	3.32e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.8e-07	3.24e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.71e-07	3.18e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.71e-07	3.18e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.6e-07	3.1e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.6e-07	3.1e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	4.31e-07	2.91e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.2e-07	2.84e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	3.91e-07	2.64e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.16e-07	1.46e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.11e-07	1.43e-05	CbGpPWpGaD
